Skip to main content
Top
Published in: Journal of General Internal Medicine 6/2013

01-06-2013 | Original Research

Use of a Computerized Order Set to Increase Prescription of Calcium and Vitamin D Supplementation in Patients Receiving Glucocorticoids

Authors: Minna J. Kohler, MD, Matxalen Amezaga, MD, James Drozd, RPH, Susan T. Crowley, MD, Barbara Gulanski, MD, Daren R. Anderson, MD, Liana Fraenkel, MD, MPH

Published in: Journal of General Internal Medicine | Issue 6/2013

Login to get access

Abstract

BACKGROUND

American College of Rheumatology guidelines recommend that patients taking glucocorticoids also take calcium and vitamin D supplements, regardless of the dose or intended duration of glucocorticoid use, to decrease their risk of glucocorticoid-induced osteopenia or osteoporosis (GIOP).

OBJECTIVE

To increase the number of prescriptions made for calcium and vitamin D in patients who receive a prescription for glucocorticoids using an automated, computerized order set.

DESIGN

Pre-post test design.

PATIENTS

A total of 1,041 outpatients receiving care at a single VA medical center.

INTERVENTION/MAIN MEASURES

We developed an automated order set in which calcium and vitamin D were automatically co-ordered with glucocorticoid prescriptions of at least 2-week duration. We tested the impact of the order set by comparing the number of calcium and vitamin D prescriptions in patients taking glucocorticoids during a 12-month period before (T1) and after (T2) implementation. The automated order set could be modified by the treating physician, and it was not generated for patients with hypercalcemia.

KEY RESULTS

A total of 535 patients during T1 and 506 patients during T2 had a glucocorticoid prescription of at least 2-week duration. The percent of co-prescriptions for calcium increased from 37 to 49 % and vitamin D from 38 to 53 % (both p < 0.0001) after the new automated order set was implemented.

CONCLUSIONS

Implementation of an automatic prescription for calcium and vitamin D supplementation modestly increases the number of patients on glucocorticoids who are prescribed calcium and vitamin D supplementation.
Literature
1.
go back to reference Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res. 2010;62:1515–26.CrossRef Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res. 2010;62:1515–26.CrossRef
2.
go back to reference Lane NE, Lukert B. The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am. 1998;27:465–83.PubMedCrossRef Lane NE, Lukert B. The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am. 1998;27:465–83.PubMedCrossRef
3.
go back to reference Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford). 2000;39:1383–9.CrossRef Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford). 2000;39:1383–9.CrossRef
4.
go back to reference Van Staa TP, Geusens P, Pols HA, de Laet C, Leufkens HG, Cooper C. A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM. 2005;98:191–8.PubMedCrossRef Van Staa TP, Geusens P, Pols HA, de Laet C, Leufkens HG, Cooper C. A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM. 2005;98:191–8.PubMedCrossRef
5.
go back to reference Adachi JD, Benson WG, Bianchi F, et al. Calcium and vitamin D supplementation prevents bone loss in the spine secondary to low dose corticosteroids. J Rheumatol. 1996;125:995–1000. Adachi JD, Benson WG, Bianchi F, et al. Calcium and vitamin D supplementation prevents bone loss in the spine secondary to low dose corticosteroids. J Rheumatol. 1996;125:995–1000.
6.
go back to reference Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med. 1996;125:961–8.PubMedCrossRef Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med. 1996;125:961–8.PubMedCrossRef
7.
go back to reference Dyksman TR, Haralson KM, Gluck OS, et al. Effect of oral 1, 25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 1984;27:1336–43.CrossRef Dyksman TR, Haralson KM, Gluck OS, et al. Effect of oral 1, 25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 1984;27:1336–43.CrossRef
8.
go back to reference Yood RA, Harrold LR, Fish L, et al. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. Arch Intern Med. 2001;161:1322–7.PubMedCrossRef Yood RA, Harrold LR, Fish L, et al. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. Arch Intern Med. 2001;161:1322–7.PubMedCrossRef
9.
go back to reference Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rate and predictors of care in an academic rheumatology practice. Arthritis Rheum. 2002;46:3136–42.PubMedCrossRef Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rate and predictors of care in an academic rheumatology practice. Arthritis Rheum. 2002;46:3136–42.PubMedCrossRef
10.
go back to reference Curtis JR, Westfall AO, Allison J, et al. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users. Arch Intern Med. 2007;167:591–6.PubMedCrossRef Curtis JR, Westfall AO, Allison J, et al. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users. Arch Intern Med. 2007;167:591–6.PubMedCrossRef
11.
go back to reference Guzman-Clark JR, Fang MA, Sehl ME, Traylor L, Hahn TJ. Barriers in the management of glucocorticoid-induced osteoporosis. Arthritis Rheum. 2007;57:140–6.PubMedCrossRef Guzman-Clark JR, Fang MA, Sehl ME, Traylor L, Hahn TJ. Barriers in the management of glucocorticoid-induced osteoporosis. Arthritis Rheum. 2007;57:140–6.PubMedCrossRef
12.
go back to reference Solomon DH, Katz JN, La Tourette AM, Coblyn JS. Multifaceted intervention to improve rheumatologists’ management of glucocorticoid-induced osteoporosis. J Rheumatol. 2004;51:383–7. Solomon DH, Katz JN, La Tourette AM, Coblyn JS. Multifaceted intervention to improve rheumatologists’ management of glucocorticoid-induced osteoporosis. J Rheumatol. 2004;51:383–7.
13.
go back to reference Curtis JR, Westfall AO, Allison JJ, et al. Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum. 2005;52:2485–94.PubMedCrossRef Curtis JR, Westfall AO, Allison JJ, et al. Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum. 2005;52:2485–94.PubMedCrossRef
14.
go back to reference Naunton M, Peterson GM, Jones G, Griffin GM, Bleasel MD. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis. J Rheumatol. 2004;31:550–6.PubMed Naunton M, Peterson GM, Jones G, Griffin GM, Bleasel MD. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis. J Rheumatol. 2004;31:550–6.PubMed
15.
go back to reference Blumenthal D, Tavenner M. The “meaningful use” regulation for electronic health records. N Engl J Med. 2010;363:501–4.PubMedCrossRef Blumenthal D, Tavenner M. The “meaningful use” regulation for electronic health records. N Engl J Med. 2010;363:501–4.PubMedCrossRef
16.
go back to reference McKibbon KA, Lokker C, Handler SM, et al. The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials. JAMIA. 2012;19:22–30.PubMed McKibbon KA, Lokker C, Handler SM, et al. The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials. JAMIA. 2012;19:22–30.PubMed
17.
go back to reference Payne TH, Hoey PJ, Nichol P, Lovis C. Preparation and use of preconstructed orders, order sets, and order menus in a computerized provider order entry system. J Am Med Inform Assoc. 2003;10:322–9.PubMedCrossRef Payne TH, Hoey PJ, Nichol P, Lovis C. Preparation and use of preconstructed orders, order sets, and order menus in a computerized provider order entry system. J Am Med Inform Assoc. 2003;10:322–9.PubMedCrossRef
18.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.PubMedCrossRef
19.
go back to reference Haynes RB, Wilczynski NL, Computerized Clinical Decision Support System (CCDSS) Systematic Review Team. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: methods of a decision-maker-researcher partnership systematic review. Implement Sci. 2010;5:12.PubMedCrossRef Haynes RB, Wilczynski NL, Computerized Clinical Decision Support System (CCDSS) Systematic Review Team. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: methods of a decision-maker-researcher partnership systematic review. Implement Sci. 2010;5:12.PubMedCrossRef
20.
go back to reference CCDSS Systematic Review Team, Hemens BJ, Holbrook A, Tonkin M, Mackay JA, Weise-Kelly L, Navarro T, Wilczynski NL, Haynes RB. Computerized clinical decision support systems for drug prescribing and management: A decision-maker-research partnership systematic review. Implement Sci. 2011;6:89.PubMedCrossRef CCDSS Systematic Review Team, Hemens BJ, Holbrook A, Tonkin M, Mackay JA, Weise-Kelly L, Navarro T, Wilczynski NL, Haynes RB. Computerized clinical decision support systems for drug prescribing and management: A decision-maker-research partnership systematic review. Implement Sci. 2011;6:89.PubMedCrossRef
21.
go back to reference Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330:765.PubMedCrossRef Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330:765.PubMedCrossRef
Metadata
Title
Use of a Computerized Order Set to Increase Prescription of Calcium and Vitamin D Supplementation in Patients Receiving Glucocorticoids
Authors
Minna J. Kohler, MD
Matxalen Amezaga, MD
James Drozd, RPH
Susan T. Crowley, MD
Barbara Gulanski, MD
Daren R. Anderson, MD
Liana Fraenkel, MD, MPH
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 6/2013
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2360-1

Other articles of this Issue 6/2013

Journal of General Internal Medicine 6/2013 Go to the issue

Clinical Practice: Clinical Vignettes

Vitamin C Deficiency in an Anticoagulated Patient

Healing Arts: Materia Medica

Open Wide

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.